WASHINGTON — Governments, health systems and technology developers reported progress in several personalized healthcare initiatives this month, highlighting advances in precision medicine, artificial intelligence and health data integration aimed at improving patient care and expanding access to tailored treatments.
The developments come as policymakers and healthcare organizations increase investment in technologies that use clinical, genomic and other health data to support individualized prevention, diagnosis and treatment. Recent actions by international health authorities and healthcare providers have focused on expanding access while addressing concerns related to equity, regulation and data governance.
In May, member states of the World Health Organization approved a resolution on precision medicine during the Seventy-ninth World Health Assembly, committing to strengthen national policies, infrastructure and workforce capacity for more personalized approaches to care. The resolution calls for the development of a global strategy and additional guidance to support implementation across healthcare systems. WHO officials said precision medicine is already being used in areas including cancer treatment, rare disease diagnosis and infectious disease management.
“Precision medicine is not an aspirational idea for health delivery in the future – it is already transforming lives across the world,” WHO science officials said in statements accompanying the resolution.
Healthcare technology companies also reported advances in tools designed to support more individualized care. Earlier this month, GE HealthCare announced U.S. regulatory clearance for updated artificial intelligence software intended to assist radiation oncology teams in treatment planning. The company said the technology could help clinicians reduce planning time and deliver more personalized treatment approaches for cancer patients.
In another development, Philips reported findings from its 2026 Future Health Index survey indicating that many healthcare professionals are increasingly using AI-based tools in clinical settings. According to the survey, clinicians reported gains in efficiency and patient-management capacity, although many respondents also cited ongoing challenges involving training and implementation.
Public-sector efforts have also focused on strengthening health data systems that support personalized care. In the United States, federal health officials reported continued expansion of national health information exchange networks intended to improve access to electronic health records and support data-driven healthcare decisions. The Department of Health and Human Services said interoperability initiatives are designed to reduce administrative burdens and improve patient access to health information.
Health officials and industry representatives have emphasized that broader adoption of personalized healthcare technologies will require continued investment in digital infrastructure, workforce training and safeguards for patient privacy. WHO member states also noted concerns that unequal access to genomic research, laboratory capacity and health technology could widen disparities if not addressed.
As of Sunday, governments, healthcare providers and technology developers said work was continuing on national and international initiatives intended to expand precision medicine and personalized healthcare services. Several organizations reported that additional policy recommendations, technical guidance and technology deployments are expected later this year.
